Reaction Details Report a problem with these data
Target
Tyrosine-protein kinase JAK2
Ligand
BDBM364403
Substrate
n/a
Meas. Tech.
In Vitro Activity Assay
IC50
3110±n/a nM
Citation
 Gray, NS; Tan, L Hydrophobically tagged janus kinase inhibitors and uses thereof US Patent  US9862688 Publication Date 1/9/2018 
Target
Name:
Tyrosine-protein kinase JAK2
Synonyms:
JAK-2 | JAK2 | JAK2_HUMAN | Janus kinase 2 | Janus kinase 2 (JAK2) | Janus kinase 2 (a protein tyrosine kinase)
Type:
Protein
Mol. Mass.:
130684.68
Organism:
Homo sapiens (Human)
Description:
O60674
Residue:
1132
Sequence:
MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
  
Inhibitor
Name:
BDBM364403
Synonyms:
US9862688, Compound 2
Type:
Small organic molecule
Emp. Form.:
C40H51ClN8O3
Mol. Mass.:
727.338
SMILES:
COc1cc(ccc1Nc1ncc(Cl)c(NCc2cccc(NC(=O)C=C)c2)n1)N1CCN(CCCNC(=O)CC2[C@H]3C[C@@H]4C[C@H](C[C@@H]2C4)C3)CC1 |r,wD:41.54,45.53,47.49,43.46,THB:46:45:40.47.48:42,44:45:40:48.43.42,(2.67,-1.92,;2.67,-.38,;1.33,.39,;,-.38,;-1.33,.39,;-1.33,1.93,;,2.7,;1.33,1.93,;2.67,2.7,;4,1.93,;4,.39,;5.33,-.38,;6.67,.39,;8,-.38,;6.67,1.93,;8,2.7,;9.34,1.93,;10.67,2.7,;10.67,4.24,;12,5.01,;13.34,4.24,;13.34,2.7,;14.67,1.93,;16,2.7,;16,4.24,;17.34,1.93,;18.67,2.7,;12,1.93,;5.33,2.7,;-2.67,-.38,;-2.67,-1.92,;-4,-2.69,;-5.33,-1.92,;-6.67,-2.69,;-8,-1.92,;-9.34,-2.69,;-10.67,-1.92,;-12,-2.69,;-12,-4.23,;-13.34,-1.92,;-14.67,-2.69,;-14.67,-4.23,;-16.4,-3.74,;-18.67,-1.92,;-18.67,-3.46,;-17.34,-4.23,;-17.34,-2.69,;-16,-1.92,;-17.34,-1.15,;-16,-5.01,;-5.33,-.38,;-4,.39,)|
Structure:
Search PDB for entries with ligand similarity: